Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

HeartBeam granted Patent for a synthesized 12-lead ECG

HeartBeam granted Patent for a synthesized 12-lead ECG

HeartBeam (NASDAQ:BEAT) Inc CEO Branislav Vajdic joined Steve Darling from Proactive to share news about the company that as developed the first and only 3D-vector ECG platform for heart attack detection. Vajdic shares more details about their system including HeartBeam AIMIGo which is the first and only credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection. The company has just been granted a patent for that 12 lead ECG.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK